Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy

Cellular Oncology

Volumn 36, Issue 2, 2013, Pages 155-167

  Algamas Dimantov, Anna ^a   Yehuda Shnaidman, Einav ^a   Peri, Irena ^a   Schwartz, Betty ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Colon carcinoma; HDAC inhibitors; HNF 4 ; MUC4

Indexed keywords

CYCLINE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HISTONE H3; HISTONE H4; MUCIN 4; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1; TRICHOSTATIN A;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL STRAIN HT29; COLON CARCINOMA; CONTROLLED STUDY; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ACETYLATION; BLOTTING, WESTERN; BUTYRATES; CACO-2 CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE NUCLEAR FACTOR 4; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HT29 CELLS; HUMANS; HYDROXAMIC ACIDS; MUCIN-4; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84876480047     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0123-3     Document Type: Article

References (57)

1. F.M. Sladek, Orphan receptor HNF-4 and liver-specific gene expression. Receptor 3, 223-232 (1993)
2. A.J. Watt, W.D. Garrison, S.A. Duncan, HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 37, 1249-1253 (2003)
3. A.L. Cattin, J. Le Beyec, F. Barreau, S. Saint-Just, A. Houllier, F.J. Gonzalez, S. Robine, M. Pincon-Raymond, P. Cardot, M. Lacasa, A. Ribeiro, Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium. Mol. Cell. Biol. 29, 6294-6308 (2009)
4. W.D. Garrison, M.A. Battle, C. Yang, K.H. Kaestner, F.M. Sladek, S.A. Duncan, Hepatocyte nuclear factor 4alpha is essential for embryonic development of the mouse colon. Gastroenterology 130, 1207-1220 (2006)
5. S.A. Duncan, K. Manova, W.S. Chen, P. Hoodless, D.C. Weinstein, R.F. Bachvarova, J.E. Darnell Jr., Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proc. Natl. Acad. Sci. U. S. A. 91, 7598-7602 (1994)
6. B. Schwartz, A. Algamas-Dimantov, R. Hertz, J. Nataf, A. Kerman, I. Peri, J. Bar-Tana, Inhibition of colorectal cancer by targeting hepatocyte nuclear factor-4alpha. Int. J. Cancer 124, 1081-1089 (2009)
7. A. Algamas-Dimantov, D. Davidovsky, J. Ben-Ari, J.X. Kang, I. Peri, R. Hertz, J. Bar-Tana, B. Schwartz, Amelioration of diabesity-induced colorectal ontogenesis by omega-3 fatty acids in mice. J. Lipid Res. 53, 1056-1070 (2012)
8. J.P. Audie, A. Janin, N. Porchet, M.C. Copin, B. Gosselin, J.P. Aubert, Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J. Histochem. Cytochem. 41, 1479-1485 (1993)
9. A.P. Corfield, D. Carroll, N. Myerscough, C.S. Probert, Mucins in the gastrointestinal tract in health and disease. Front. Biosci. 6, D1321-D1357 (2001)
10. R.S. Bresalier, B. Schwartz, Y.S. Kim, Q.Y. Duh, H.K. Kleinman, P.M. Sullam, The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells. Cancer Res. 55, 2476-2480 (1995)
11. C. Shanmugam, N.C. Jhala, V.R. Katkoori, W. Wan, S. Meleth, W.E. Grizzle, U. Manne, Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer 116, 3577-3586 (2010)
12. N. Jonckheere, A. Vincent, M. Perrais, M.P. Ducourouble, A.K. Male, J.P. Aubert, P. Pigny, K.L. Carraway, J.N. Freund, I.B. Renes, I. Van Seuningen, The human mucin MUC4 is transcriptionally regulated by caudal-related homeobox, hepatocyte nuclear factors, forkhead box A, and GATA endodermal transcription factors in epithelial cancer cells. J. Biol. Chem. 282, 22638-22650 (2007)
13. G.A. Kozloski, C.A. Carraway, K.L. Carraway, Mechanistic and signaling analysis of Muc4-ErbB2 signaling module: new insights into the mechanism of ligand-independent ErbB2 activity. J. Cell. Physiol. 224, 649-657 (2010)
14. S. Ropero, M. Esteller, The role of histone deacetylases (HDACs) in human cancer. Mol. Oncol. 1, 19-25 (2007)
15. M. Esteller, CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21, 5427-5440 (2002)
16. S. Minucci, P.G. Pelicci, Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6, 38-51 (2006)
17. H.Y. Lin, C.S. Chen, S.P. Lin, J.R. Weng, Targeting histone deacetylase in cancer therapy. Med. Res. Rev. 26, 397-413 (2006)
18. A.J. Wilson, D.S. Byun, N. Popova, L.B. Murray, K. L'Italien, Y. Sowa, D. Arango, A. Velcich, L.H. Augenlicht, J.M. Mariadason, Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 281, 13548-13558 (2006)
19. N. Gurvich, O.M. Tsygankova, J.L. Meinkoth, P.S. Klein, Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res. 64, 1079-1086 (2004)
20. J.M. Mariadason, A. Velcich, A.J. Wilson, L.H. Augenlicht, P.R. Gibson, Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation. Gastroenterology 120, 889-899 (2001)
21. J.M. Mariadason, K.L. Rickard, D.H. Barkla, L.H. Augenlicht, P.R. Gibson, Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation. J. Cell. Physiol. 183, 347-354 (2000)
22. S. Shankar, R.K. Srivastava, Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis. Adv. Exp. Med. Biol. 615, 261-298 (2008)
23. P.A. Marks, V.M. Richon, R.A. Rifkind, Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer Inst. 92, 1210-1216 (2000)
24. M. Barshishat, S. Polak-Charcon, B. Schwartz, Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells. Br. J. Cancer 82, 195-203 (2000)
25. H.L. Newmark, J.R. Lupton, C.W. Young, Butyrate as a differentiating agent: pharmacokinetics, analogues and current status. Cancer Lett. 78, 1-5 (1994)
26. T. Vanhaecke, P. Papeleu, G. Elaut, V. Rogiers, Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr. Med. Chem. 11, 1629-1643 (2004)
27. D. Massillon, I.J. Arinze, C. Xu, F. Bone, Regulation of glucose-6-phosphatase gene expression in cultured hepatocytes and H4IIE cells by short-chain fatty acids: role of hepatic nuclear factor-4alpha. J. Biol. Chem. 278, 40694-40701 (2003)
28. B. Schwartz, R.S. Bresalier, Y.S. Kim, The role of mucin in colon-cancer metastasis. Int. J. Cancer 52, 60-65 (1992)
29. I. Lavi, D. Levinson, I. Peri, Y. Tekoah, Y. Hadar, B. Schwartz, Chemical characterization, antiproliferative and antiadhesive properties of polysaccharides extracted from Pleurotus pulmonarius mycelium and fruiting bodies. Appl. Microbiol. Biotechnol. 85, 1977-1990 (2010)
30. I. Lavi, D. Levinson, I. Peri, L. Nimri, Y. Hadar, B. Schwartz, Orally administered glucans from the edible mushroom Pleurotus pulmonarius reduce acute inflammation in dextran sulfate sodium-induced experimental colitis. Br. J. Nutr. 103, 393-402 (2010)
31. B. Schwartz, V.O. Melnikova, C. Tellez, A. Mourad-Zeidan, K. Blehm, Y.J. Zhao, M. McCarty, L. Adam, M. Bar-Eli, Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Oncogene 26, 4049-4058 (2007)
32. M. Barshishat, I. Levi, D. Benharroch, B. Schwartz, Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line. Br. J. Cancer 87, 1314-1320 (2002)
33. S. Pizzi, C. Azzoni, E. Tamburini, L. Bottarelli, N. Campanini, T. D'Adda, G. Fellegara, T.V. Luong, C. Pasquali, G. Rossi, G. Delle Fave, R. Camisa, C. Bordi, G. Rindi, Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability. Endocr. Relat. Cancer 15, 1013-1024 (2008)
34. S. Kim, J.K. Kang, Y.K. Kim, D.W. Seo, S.H. Ahn, J.C. Lee, C.H. Lee, J.S. You, E.J. Cho, H.W. Lee, J.W. Han, Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites. Biochem. Biophys. Res. Commun. 342, 1168-1173 (2006)
35. P.A. Marks, W.S. Xu, Histone deacetylase inhibitors: potential in cancer therapy. J. Cell. Biochem. 107, 600-608 (2009)
36. P. Hatzis, I. Talianidis, Regulatory mechanisms controlling human hepatocyte nuclear factor 4alpha gene expression. Mol. Cell. Biol. 21, 7320-7330 (2001)
37. T. Tanaka, S. Jiang, H. Hotta, K. Takano, H. Iwanari, K. Sumi, K. Daigo, R. Ohashi, M. Sugai, C. Ikegame, H. Umezu, Y. Hirayama, Y. Midorikawa, Y. Hippo, A. Watanabe, Y. Uchiyama, G. Hasegawa, P. Reid, H. Aburatani, T. Hamakubo, J. Sakai, M. Naito, T. Kodama, Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J. Pathol. 208, 662-672 (2006)
38. M. Sugai, H. Umezu, T. Yamamoto, S. Jiang, H. Iwanari, T. Tanaka, T. Hamakubo, T. Kodama, M. Naito, Expression of hepatocyte nuclear factor 4 alpha in primary ovarian mucinous tumors. Pathol. Int. 58, 681-686 (2008)
39. R.S. Bresalier, Y. Niv, J.C. Byrd, Q.Y. Duh, N.W. Toribara, R.W. Rockwell, R. Dahiya, Y.S. Kim, Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J. Clin. Invest. 87, 1037-1045 (1991)
40. S.F. Kuan, J.C. Byrd, C.B. Basbaum, Y.S. Kim, Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res. 47, 5715-5724 (1987)
41. N. Yamada, Y. Nishida, H. Tsutsumida, M. Goto, M. Higashi, M. Nomoto, S. Yonezawa, Promoter CpG methylation in cancer cells contributes to the regulation of MUC4. Br. J. Cancer 100, 344-351 (2009)
42. H. Albrecht, K.L. Carraway 3rd, MUC1 and MUC4: switching the emphasis from large to small. Cancer Biother. Radiopharm. 26, 261-271 (2011)
43. M.A. Hollingsworth, B.J. Swanson, Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4, 45-60 (2004)
44. K. Hosono, H. Endo, H. Takahashi, M. Sugiyama, T. Uchiyama, K. Suzuki, Y. Nozaki, K. Yoneda, K. Fujita, M. Yoneda, M. Inamori, A. Tomatsu, T. Chihara, K. Shimpo, H. Nakagama, A. Nakajima, Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase. Mol. Carcinog. 49, 662-671 (2010)
45. K. Furukawa, T. Sato, T. Katsuno, T. Nakagawa, Y. Noguchi, A. Tokumasa, K. Yokote, O. Yokosuka, Y. Saito, Smad3 contributes to positioning of proliferating cells in colonic crypts by inducing EphB receptor protein expression. Biochem. Biophys. Res. Commun. 405, 521-526 (2011)
46. F.J. Kubben, A. Peeters-Haesevoets, L.G. Engels, C.G. Baeten, B. Schutte, J.W. Arends, R.W. Stockbrugger, G.H. Blijham, Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut 35, 530-535 (1994)
47. T. Saandi, F. Baraille, L. Derbal-Wolfrom, A.L. Cattin, F. Benahmed, E. Martin, P. Cardot, B. Duclos, A. Ribeiro, J.N. Freund, I. Duluc, Regulation of the tumor suppressor homeogene Cdx2 by HNF4alpha in intestinal cancer. Oncogene (2012)
48. M. Ahmad, A. Hamid, A. Hussain, R. Majeed, Y. Qurishi, J.A. Bhat, R.A. Najar, A.K. Qazi, M.A. Zargar, S.K. Singh, A.K. Saxena, Understanding histone deacetylases in the cancer development and treatment: an epigenetic perspective of cancer chemotherapy, DNA cell. Biol. (2012)
49. L. Peng, E. Seto, Deacetylation of nonhistone proteins by HDACs and the implications in cancer. Handb. Exp. Pharmacol. 206, 39-56 (2011)
50. H.S. Lee, M.H. Park, S.J. Yang, H.Y. Jung, S.S. Byun, D.S. Lee, H.S. Yoo, Y.I. Yeom, S.B. Seo, Gene expression analysis in human gastric cancer cell line treated with trichostatin A and S-adenosyl-L-homocysteine using cDNA microarray. Biol. Pharm. Bull. 27, 1497-1503 (2004)
51. J.M. Mariadason, G.A. Corner, L.H. Augenlicht, Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res. 60, 4561-4572 (2000)
52. J. Serpa, F. Caiado, T. Carvalho, C. Torre, L.G. Goncalves, C. Casalou, P. Lamosa, M. Rodrigues, Z. Zhu, E.W. Lam, S. Dias, Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells. J. Biol. Chem. 285, 39211-39223 (2010)
53. H. Yoshioka, H. Kamitani, T. Watanabe, T.E. Eling, Nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin A. J. Biol. Chem. 283, 33129-33137 (2008)
54. S. Paterson, K.L. Sin, J.M. Tiang, R.F. Minchin, N.J. Butcher, Histone deacetylase inhibitors increase human arylamine N-acetyltransferase-1 expression in human tumor cells. Drug Metab. Dispos. 39, 77-82 (2011)
55. L. Pufahl, C. Katryniok, N. Schnur, B.L. Sorg, J. Metzner, M. Grez, D. Steinhilber, Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3. J. Cell. Mol. Med. (2011)
56. T. Suzuki, A. Kimura, R. Nagai, M. Horikoshi, Regulation of interaction of the acetyltransferase region of p300 and the DNA-binding domain of Sp1 on and through DNA binding. Genes Cells 5, 29-41 (2000)
57. S. Zhao, K. Venkatasubbarao, S. Li, J.W. Freeman, Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Cancer Res. 63, 2624-2630 (2003)